Nature, Vol.565, No.7738, E4-E4, 2019
PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas (vol 550, pg 133, 2017)
Lu HZ,
Liu SJ,
Zhang G,
Wu B,
Zhu YY,
Frederick DT,
Hu Y,
Zhong WQ,
Randell S,
Sadek N,
Zhang W,
Chen G,
Cheng CR,
Zeng JW,
Wu LW,
Zhang J,
Liu XM,
Xu W,
Krepler C,
Sproesser K,
Xiao M,
Miao BC,
Liu JL,
Song CD,
Liu JY,
Karakousis GC,
Schuchter LM,
Lu YL,
Mills G,
Cong YS,
Chernoff J,
Guo J,
Boland GM,
Sullivan RJ,
Wei Z,
Field J,
Amaravadi RK,
Flaherty KT,
Herlyn M,
Xu XW,
Guo W
